|
20.03.23
|
|
Hennes Mauritz (H M, H&M) Underweight
|
JP Morgan Chase & Co.
|
|
20.03.23
|
|
Hennes Mauritz (H M, H&M) Sector Perform
|
RBC Capital Markets
|
|
16.03.23
|
|
Hennes Mauritz (H M, H&M) Buy
|
Deutsche Bank AG
|
|
15.03.23
|
|
Hennes Mauritz (H M, H&M) Buy
|
Deutsche Bank AG
|
|
15.03.23
|
|
Hennes Mauritz (H M, H&M) Neutral
|
UBS AG
|
|
15.03.23
|
|
Hennes Mauritz (H M, H&M) Sector Perform
|
RBC Capital Markets
|
|
15.03.23
|
|
Hennes Mauritz (H M, H&M) Hold
|
Jefferies & Company Inc.
|
|
15.03.23
|
|
AstraZeneca Buy
|
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
|
|
14.03.23
|
|
Novo Nordisk Buy
|
Deutsche Bank AG
|
|
14.03.23
|
|
AstraZeneca Buy
|
Deutsche Bank AG
|
|
13.03.23
|
|
AstraZeneca Buy
|
Deutsche Bank AG
|
|
10.03.23
|
|
AstraZeneca Neutral
|
UBS AG
|
|
09.03.23
|
|
Nokia Neutral
|
UBS AG
|
|
09.03.23
|
|
AstraZeneca Overweight
|
JP Morgan Chase & Co.
|
|
09.03.23
|
|
Kone Buy
|
Jefferies & Company Inc.
|
|
09.03.23
|
|
ABB (Asea Brown Boveri) Hold
|
Jefferies & Company Inc.
|
|
09.03.23
|
|
Novo Nordisk Overweight
|
JP Morgan Chase & Co.
|
|
08.03.23
|
|
Hennes Mauritz (H M, H&M) Sector Perform
|
RBC Capital Markets
|
|
07.03.23
|
|
ABB (Asea Brown Boveri) Buy
|
Goldman Sachs Group Inc.
|
|
07.03.23
|
|
Hennes Mauritz (H M, H&M) Underweight
|
JP Morgan Chase & Co.
|
|
06.03.23
|
|
Kone Sell
|
Deutsche Bank AG
|
|
02.03.23
|
|
Volvo (B) Buy
|
Goldman Sachs Group Inc.
|
|
02.03.23
|
|
AstraZeneca Overweight
|
JP Morgan Chase & Co.
|
|
27.02.23
|
|
Nokia Buy
|
Jefferies & Company Inc.
|
|
27.02.23
|
|
Nokia Buy
|
Goldman Sachs Group Inc.
|
|
23.02.23
|
|
Nokia Buy
|
Goldman Sachs Group Inc.
|
|
22.02.23
|
|
Novo Nordisk Underperform
|
Jefferies & Company Inc.
|
|
21.02.23
|
|
ABB (Asea Brown Boveri) Neutral
|
JP Morgan Chase & Co.
|
|
21.02.23
|
|
AstraZeneca Neutral
|
UBS AG
|
|
20.02.23
|
|
Hennes Mauritz (H M, H&M) Neutral
|
Goldman Sachs Group Inc.
|
|
20.02.23
|
|
Volvo (B) Buy
|
Goldman Sachs Group Inc.
|
|
17.02.23
|
|
A.P. Moeller - Maersk A-S (B) Overweight
|
JP Morgan Chase & Co.
|
|
16.02.23
|
|
AstraZeneca Buy
|
Deutsche Bank AG
|
|
15.02.23
|
|
Nokia Buy
|
Goldman Sachs Group Inc.
|
|
15.02.23
|
|
ABB (Asea Brown Boveri) Buy
|
UBS AG
|
|
14.02.23
|
|
ABB (Asea Brown Boveri) Hold
|
Deutsche Bank AG
|
|
14.02.23
|
|
Nokia Outperform
|
Credit Suisse Group
|
|
13.02.23
|
|
Novo Nordisk Conviction Buy List
|
Goldman Sachs Group Inc.
|
|
10.02.23
|
|
AstraZeneca Neutral
|
UBS AG
|
|
10.02.23
|
|
AstraZeneca Buy
|
Deutsche Bank AG
|